Pharmaron

Pharmaron forms strategic partnership with AstraZeneca

Monday, October 15, 2012 11:47 AM

Pharmaron, an R&D service provider for the pharmaceutical and biotech industries, is partnering with AstraZeneca to support its global innovative medicines units.

More... »


Pharmaron to host Merck’s R&D laboratory in China

Wednesday, September 14, 2011 02:13 PM

Pharmaron has reported a strategic partnership with Merck Serono. In the framework of this partnership, Pharmaron's new campus in the Beijing economic and technological development area (BDA) will serve as home to Merck Serono's China R&D laboratory.

More... »


Pharmaron raises $40 million in financing round

Tuesday, March 1, 2011 08:42 AM

CRO Pharmaron Holding, of Irvine, Calif. and Beijing, has closed a Series C financing round totaling more than $40 million from existing investors DCM, Legend Capital and others, along with new investor GL Capital Group.

More... »

Pharmaron Beefs Up Preclinical Offerings with Bridge Labs China Acquisition

Thursday, January 14, 2010 06:54 AM

Pharmaron Holdings acquired Bridge Laboratories China this week for an undisclosed sum, building on the contract research organization’s (CRO’s) existing presence in China.  

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs